TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JAVADI M.A.; FEYZI SEPEHR; POURSALMAN H.; KARIMI SAEID; KATIBEH M.

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2010 | Volume:15 | Issue:2 (59) Page(s): 128-134

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

1,000

Download:

Cites:

Information Journal Paper

Title

TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY

Author(s)

Keywords

CYCLOSPORINEQ3

GRAFT REJECTIONQ3

SURVIVAL RATEQ3

Abstract

Purpose: To investigate the efficacy of topical CYCLOSPORINE A 2% in treating and preventing recurrent GRAFT REJECTION episodes after penetrating keratoplasty (PKP) in patients with history of previous rejection episodes.Methods: In this clinical trial, eligible PKP patients were randomly given topical CYCLOSPORINE A 2% or placebo in addition to a standard corticosteroid regimen for an episode of recurrent subepithelial or endothelial GRAFT REJECTION. Primary indications for transplantation were keratoconus, Fuchs' endothelial dystrophy, corneal stromal dystrophy, and nonvascularized scars. Topical CYCLOSPORINE and placebo were continued for 6 months. The duration of corticosteroid therapy and resolution of GRAFT REJECTION episode, the number of concurrent and subsequent rejection episodes and the rate of rejection-free survival were compared between the study groups.Results: Twenty-two eyes of 22 patients (12 men) received a combination of topical CYCLOSPORINE A 2% and betamethasone 0.1% (group 1) and 21 eyes of 21 patients (10 men) received topical betamethasone 0.1% and placebo (group 2) for an episode of recurrent GRAFT REJECTION. Mean patient age was 32.48±11.9 and 35.48±11.7 years in group 1 and 2, respectively (P=0.42). Mean follow-up period was 16.6±6.1 months in group 1 and 16.0±6.3 months in group 2 (P=0.75). The episode for which topical CYCLOSPORINE 2% or placebo was started completely resolved after 25.6±21.0 and 33.2±16.7 days in group 1 and 2, respectively (P=0.22).The rejection free graft SURVIVAL RATE was 34.8% in group 1 and 31.7% in group 2 (P=0.89).Conclusion: Adding topical CYCLOSPORINE A 2% had no further advantage over corticosteroid therapy alone to treat and prevent GRAFT REJECTION in repeated rejection.

Cites

No record.

References

No record.

Cite

APA: Copy

JAVADI, M.A., FEYZI, SEPEHR, POURSALMAN, H., KARIMI, SAEID, & KATIBEH, M.. (2010). TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY. BINA, 15(2 (59)), 128-134. SID. https://sid.ir/paper/42515/en

Vancouver: Copy

JAVADI M.A., FEYZI SEPEHR, POURSALMAN H., KARIMI SAEID, KATIBEH M.. TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY. BINA[Internet]. 2010;15(2 (59)):128-134. Available from: https://sid.ir/paper/42515/en

IEEE: Copy

M.A. JAVADI, SEPEHR FEYZI, H. POURSALMAN, SAEID KARIMI, and M. KATIBEH, “TOPICAL CYCLOSPORINE A FOR RECURRENT EPISODES OF GRAFT REJECTION AFTER PENETRATING KERATOPLASTY,” BINA, vol. 15, no. 2 (59), pp. 128–134, 2010, [Online]. Available: https://sid.ir/paper/42515/en

Related Journal Papers